159 related articles for article (PubMed ID: 25716519)
21. Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.
Toy M; Hutton D; Harris AM; Nelson N; Salomon JA; So S
Clin Infect Dis; 2022 Jan; 74(2):210-217. PubMed ID: 33956937
[TBL] [Abstract][Full Text] [Related]
22. A qualitative exploration of enablers for hepatitis B clinical management among ethnic Chinese in Australia.
Xiao Y; Wallace J; Thompson A; Hellard M; van Gemert C; Holmes JA; Croagh C; Richmond J; Papaluca T; Hall S; Hong T; Demediuk B; Iser D; Ryan M; Desmond P; Visvanathan K; Howell J
J Viral Hepat; 2021 Jun; 28(6):925-933. PubMed ID: 33662159
[TBL] [Abstract][Full Text] [Related]
23. Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults.
He WQ; Matthews GV; Liu B
Dig Dis Sci; 2022 Jun; 67(6):2600-2607. PubMed ID: 33945063
[TBL] [Abstract][Full Text] [Related]
24. Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection.
McMahon BJ
Am J Med; 2008 Dec; 121(12 Suppl):S45-52. PubMed ID: 19185074
[TBL] [Abstract][Full Text] [Related]
25. Economic implications of entecavir treatment in suppressing viral replication in chronic hepatitis B (CHB) patients in China from a perspective of the Chinese Social Security program.
Yuan Y; Iloeje U; Li H; Hay J; Yao GB
Value Health; 2008 Mar; 11 Suppl 1():S11-22. PubMed ID: 18387054
[TBL] [Abstract][Full Text] [Related]
26. Bridging the access gap: Medicare ineligibility in people living with chronic hepatitis B.
MacLachlan JH; Cowie BC
Intern Med J; 2019 Jan; 49(1):122-125. PubMed ID: 30680906
[TBL] [Abstract][Full Text] [Related]
27. Responding to Australia's National Hepatitis B Strategy 2010-13: gaps in knowledge and practice in relation to Indigenous Australians.
Olsen A; Wallace J; Maher L
Aust J Prim Health; 2014; 20(2):134-42. PubMed ID: 24216010
[TBL] [Abstract][Full Text] [Related]
28. Management of chronic hepatitis B.
Ghany MG; Doo EC
Gastroenterol Clin North Am; 2004 Sep; 33(3):563-79, ix. PubMed ID: 15324944
[TBL] [Abstract][Full Text] [Related]
29. Modelling jurisdictional disparities in the cascade of care for chronic hepatitis B in Australia: impact of treatment uptake on mortality.
McCulloch K; Romero N; Allard N; MacLachlan JH; Cowie BC
Aust N Z J Public Health; 2023 Feb; 47(1):100011. PubMed ID: 36638581
[TBL] [Abstract][Full Text] [Related]
30. Barriers to Accessing Testing and Treatment for Chronic Hepatitis B in Afghan, Rohingyan, and South Sudanese Populations in Australia.
Sievert K; O'Neill P; Koh Y; Lee JH; Dev A; Le S
J Immigr Minor Health; 2018 Feb; 20(1):140-146. PubMed ID: 28120131
[TBL] [Abstract][Full Text] [Related]
31. Chronic hepatitis B--what's new?
MacLachlan J; Cowie B
Aust Fam Physician; 2013 Jul; 42(7):448-51. PubMed ID: 23826594
[TBL] [Abstract][Full Text] [Related]
32. Current trends in chronic hepatitis B management: results of a questionnaire.
Les I; García-Martínez R; Córdoba J; Quintana M; Esteban R; Buti M
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1177-83. PubMed ID: 19430301
[TBL] [Abstract][Full Text] [Related]
33. Molecular methods in the diagnosis and management of chronic hepatitis B.
Vivekanandan P; Singh OV
Expert Rev Mol Diagn; 2010 Oct; 10(7):921-35. PubMed ID: 20964611
[TBL] [Abstract][Full Text] [Related]
34. Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B.
Sayan M; Akhan SC
Int J Infect Dis; 2011 Oct; 15(10):e722-6. PubMed ID: 21784687
[TBL] [Abstract][Full Text] [Related]
35. Challenges in managing patients in Australia with chronic hepatitis B: the General Practitioners' perspective.
Wallace J; Hajarizadeh B; Richmond J; McNally S
Aust N Z J Public Health; 2013 Oct; 37(5):405-10. PubMed ID: 24090321
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and clinical features of childhood chronic hepatitis B infection diagnosed in England.
Ladhani SN; Flood JS; Amirthalingam G; Mieli-Vergani G; Bansal S; Davison S; Naik S; Riordan A; Shingadia D; Tudor-Williams G; Sira J; Kelly DA; Ramsay ME;
Pediatr Infect Dis J; 2014 Feb; 33(2):130-5. PubMed ID: 24418835
[TBL] [Abstract][Full Text] [Related]
37. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.
Idris BI; Brosa M; Richardus JH; Esteban R; Schalm SW; Buti M
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):320-6. PubMed ID: 18334876
[TBL] [Abstract][Full Text] [Related]
38. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Veldhuijzen IK; Toy M; Hahné SJ; De Wit GA; Schalm SW; de Man RA; Richardus JH
Gastroenterology; 2010 Feb; 138(2):522-30. PubMed ID: 19879275
[TBL] [Abstract][Full Text] [Related]
39. How to improve access to therapy in hepatitis B patients.
Subic M; Zoulim F
Liver Int; 2018 Feb; 38 Suppl 1():115-121. PubMed ID: 29427482
[TBL] [Abstract][Full Text] [Related]
40. Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey.
Papatheodoridis G; Sypsa V; Kantzanou M; Nikolakopoulos I; Hatzakis A
J Viral Hepat; 2015 Apr; 22(4):409-15. PubMed ID: 25209157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
